glp-1 addiction trials IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target GLP-1 Anti-Obesity Rx and Alcohol

Taylor, D., Lunny, C., Wong, T., Gilbert, M., Li, N., Lester, R., Krajden, M., Hoang, L., & Ogilvie, G

It is well known that obesity lowers levels of testosterone, which is an essential hormone for the production of sperm and therefore for fertility

Mir Ali, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, told Medical News Today : As these medications increase in use and popularity, we will likely see more effects as people achieve their weight loss goals

Barkoudah E, Skali H, Uno H, Solomon SD, Pfeffer MA

before confusion, delays, or access issues ever reach the patient or provider

Clinical effectiveness of combination therapy with dulaglutide, SGLT2 inhibitor and metformin with or without insulin in Indian adults with type 2 diabetes: a real-world retrospective study